California medical device maker Bausch + Lomb announced today that it won FDA approval for its 1st-of-its-kind Trulign Toric intraocular lens.
The regulatory approval grants B+L permission to market the lens in the U.S. for treatment of astigmatism as well as improving vision across a natural range of focus without the use of glasses.